BEAT HeartBeam Corporation: ערך חשבונאי למניה

HeartBeam, Inc. (BEAT) is integrating bioethics and energy efficiency principles into its developments. The project is currently in the FDA certification phase, meaning asset valuations remain venture-based. The daily price action of the book value per share visualizes these processes, where the value of 0.15 expresses the metric level. Market capitalization is driven by demand from cardiac centers for compact 3D-ECG systems designed for rapid myocardial infarction diagnostics.

Diversifying the implementation channels for 3D-ECG at HeartBeam, Inc. (BEAT) requires stable capital; therefore, analyzing the book value per common share allows for an assessment of the business's actual asset backing, excluding market noise. This chart reflects the difference between total assets and liabilities divided by the number of shares, signaling potential dilution risks or the gradual write-down of illiquid assets.